Gonadotropin-releasing hormone agonist reduces aromatase cytochrome p450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis

Gynecologic and Obstetric Investigation

Volumn 68, Issue 2, 2009, Pages 73-81

  Kim, Young Ah ^a   Kim, Mi Ran ^b   Lee, Jae Hoon ^b,c   Kim, Ji Yeon ^a   Hwang, Kyung Joo ^b   Kim, Han Seong ^a   Lee, Eung Soo ^a  

^a Inje University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Ajou University   (South Korea)

Author keywords

Aromatase; COX 2; Endometriosis; Gonadotropin releasing hormone agonist; Stromal cell culture

Indexed keywords

AROMATASE; CYCLOOXYGENASE 2; CYTOCHROME P450; LEUPRORELIN; LUCRIN DEPOT; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; ENDOMETRIUM TUMOR; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LAPAROSCOPIC SURGERY; PRIORITY JOURNAL; STROMA CELL; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WESTERN BLOTTING;

AROMATASE; CELL CULTURE TECHNIQUES; CYCLOOXYGENASE 2; CYTOCHROME P-450 ENZYME SYSTEM; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; LEUPROLIDE;

EID: 65449164259     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000214844     Document Type: Article

References (24)

1. 2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 1997; 82: 600-606.
2. Huang JC, Liu DY, Yadollahi S, Wu KK, Dawood MY: Interleukin-1 β induces cyclooxygenase- 2 gene expression in cultured endometrial stromal cells. J Clin Endocrinol Metab 1998; 83: 538-541. (Pubitemid 28496536)
3. Yoshino O, Osuga Y, Hirota Y, Koga K, Hirata T, Harada M, et al: Possible pathophysiological roles of mitogen-activated protein kinases in endometriosis. Am J Reprod Immunol 2004; 52: 306-311. (Pubitemid 39585717)
4. Dlugi AM, Miller JD, Knittle J: Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double blind study. Fertil Steril 1990; 54: 419-427. (Pubitemid 20321389)
5. Henzl MR, Kwei L: Efficacy and safety of nafarelin in the treatment of endometriosis. Am J Obstet Gynecol 1990; 162: 570-574. (Pubitemid 20068543)
6. Ishihara H, Kitawaki J, Kado N, Koshiba H, Fushiki S, Honjo H: Gondadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril 2003; 79(suppl 1):735-742. (Pubitemid 36279678)
7. Cheng KW, Leung PC: The expression, regulation and signal transduction pathways of the mammalian gonadotropin-releasing hormone receptor. Can J Physiol Pharmacol 2000; 78: 1029-1052. (Pubitemid 32109433)
8. Klausen C, Chang JP, Habibi HR: Multiplicity of gonadotropin-releasing hormone signaling: a comparative perspective. Prog Brain Res 2002; 141: 111-128. (Pubitemid 35460827)
9. Bourgain C, Ubaldi F, Tavaniotou A, Smitz J, Van Steirteghem AC, Devroey P: Endometrial hormone receptor and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome. Fertil Steril 2002; 78: 237-244. (Pubitemid 34845894)
10. Osteen KG, Hill GA, Hargrove JT, Gorstein F: Development of a method to isolate and culture highly purified populations of stromal and epithelial cells from human endometrial biopsy specimen. Fertil Steril 1989; 52: 965-972.
11. Grundker C, Gunthert AR, Millar RP, Emons G: Expression of gonadotropin-releasing hormone II (GnRH II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab 2002; 87: 1427-1430. (Pubitemid 36121120)
12. Chou CS, MacCalman CD, Leung PC: Differential effects of gonadotropin-releasing hormone I and II on the urokinase-type plasminogen activator/plasminogen activator inhibitor system in human decidual stromal cells in vitro. J Clin Endocrinol Metab 2003; 88: 3806-3815.
13. Chou CS, Zhu H, MacCalman CD, Leung PC: Regulatory effects of gonadotropin-releasing hormone (GnRH) I and GnRH II on the levels of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of metalloproteinases-1 in primary cultures of human extravillous cytotrophoblasts. J Clin Endocrionol Metab 2003; 88: 4781-4790. (Pubitemid 37357526)
14. Dou Q, Tarnuzzer RW, Williams RS, Schultz GS, Chegini N: Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotropin releasing hormone agonist-induced tumor regression. Mol Hum Reprod 1997; 3: 1005-1014. (Pubitemid 127509967)
15. Cheon KW, Lee HS, Parhar IS, Kang IS: Expression of the second isoform of gonadotropin- releasing hormone (GnRH-II) in human endometrium throughout the menstrual cycle. Mol Hum Reprod 2001; 7: 447-452.
16. Imai A, Takagi A, Tamaya T: Gonadotropinreleasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro. Am J Obstet Gynecol 2000; 182: 1142-1146. (Pubitemid 30353302)
17. Noble LS, Simpson ER, Johns A, Bulun SE: Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996; 81: 174-179.
18. Shozu M, Sumitani H, Segawa T, Yang HJ, Murakami K, Inoue M: Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate. J Clin Endocrinol Metab 2001; 86: 5405-5411. (Pubitemid 33070267)
19. Murakami K, Nomura K, Shinohara K, Kasai T, Shozu M, Inoue M: Danazol inhibits aromatase activity of endometriosis-derived stromal cells by a competitive mechanism. Fertil Steril 2006; 86: 291-297. (Pubitemid 44118971)
20. Ferreira SH, Vane JR: Prostaglandins: their disappearance from and release into the circulation. Nature 1967; 216: 868-873.
21. Ota H, Igarashi S, Sasaki M, Tanaka T: Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 2001; 16: 561-566. (Pubitemid 32218810)
22. Chishima F, Hayakawa S, Sugita K, Kinukawa N, Aleemuzzaman S, Nemoto N, et al: Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 2002; 48: 50-56. (Pubitemid 34727375)
23. Wu MH, Wang CA, Lin CC, Chen LC, Chang WC, Tsai SJ: Distinct regulation of cyclooxygenase- 2 by interleukin-1 β in normal and endometrotic stromal cells. J Clin Endocrinol Metab 2005; 90: 286-295.
24. Tamura M, Sebastian S, Yang S, Gurates B, Fang Z, Bulun SE: Interleukin-1 β elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2. J Clin Endocrinol Metab 2002; 87: 3263-3273. (Pubitemid 34816375)